“Currently, there's no treatment or vaccination on the market for human metapneumovirus, and there’s no combination vaccine,” said Vale-Freeburg, a Velocity sub-investigator. “So, its very ...

Vaccine Clinical trial Pneumonia Human metapneumovirus Winter viruses Older adults Severe symptoms Respiratory infections. ... noting the lack of existing vaccines for these viral infections.

Human metapneumovirus, or hMPV, ... As yet, no licensed vaccine is available for the virus, but a series of candidates have entered early-stage clinical trials in the last two years.

Human metapneumovirus (HMPV) is a respiratory disease that causes flu or cold-like symptoms, but can increase risks or lead to more serious complications like bronchitis or pneumonia, particularly ...

HMPV in China: Amid the outbreak of human metapneumovirus (HMPV0 virus) in China, ... It spreads through respiratory droplets and currently has no vaccine.

Reports of human metapneumovirus (HMPV), a common respiratory illness that causes flu- and cold-like symptoms, ... noting that there's no antiviral treatment and no vaccine to prevent HMPV, ...

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.

The human metapneumovirus, also known as HMPV, is reportedly surging in China, raising questions about what the illness is and if it's a concern to those in the U.S.. Officials in India have also ...

Moderna, the first to start human testing of a COVID vaccine, began a phase 1 safety study of its candidate vaccine in a small group of healthy adults on March 16, 2020.

Despite being discovered in 2001, Human Metapneumovirus (HMPV) still lacks a vaccine, even after 24 years.

China is facing a rise in respiratory infections, notably from rhinovirus and human metapneumovirus (HMPV), particularly in children under 14. Health experts warn against the indiscriminate use of ...